VTP-45489

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameVTP-45489
Drug Alias NameVTP45489
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptors inhibitors
TargetsRetinoic acid receptors
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVitae Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A